Long‐term oral administration of glucosamine or chondroitin sulfate reduces destruction of cartilage and up‐regulation of MMP‐3 mRNA in a model of spontaneous osteoarthritis in Hartley guinea pigs
Cartilage, Articular
Glucosamine
Chondroitin Sulfates
Guinea Pigs
Drug Evaluation, Preclinical
Apoptosis
Up-Regulation
Disease Models, Animal
03 medical and health sciences
Chondrocytes
0302 clinical medicine
Osteoarthritis
Animals
Female
Matrix Metalloproteinase 3
RNA, Messenger
DOI:
10.1002/jor.22003
Publication Date:
2011-11-04T12:39:00Z
AUTHORS (6)
ABSTRACT
AbstractHistological and molecular changes were examined to investigate the effects of long‐term administration of glucosamine (GlcN) and chondroitin sulfate (CS) in a model of spontaneous osteoarthritis (OA) in Hartley guinea pigs. Three groups of female 3‐week‐old Hartley guinea pigs received GlcN, CS, and neither agent, respectively. Five animals in each group were sacrificed at 8, 12, and 18 months of age. At 8 months of age, Hartley guinea pigs had severe degeneration of knee joint cartilage, chondrocyte apoptosis, marked reduction of tissue total RNA, decreases of aggrecan and collagen type 2 mRNAs, and increases in MMP‐3 and MMP‐8 mRNAs. Long‐term administration of GlcN and CS reduced cartilage degeneration at 8 months of age. The marked loss of total RNA and the increase in MMP‐3 mRNA were also inhibited by GlcN and CS. Thus, long‐term oral administration of GlcN or CS inhibits OA progression, maintains total RNA and down‐regulates MMP‐3 mRNA in a spontaneous OA model in Hartley guinea pigs. © 2011 Orthopaedic Research Society Published by Wiley Periodicals, Inc. J Orthop Res 30:673–678, 2012
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (28)
CITATIONS (40)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....